Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: Complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall

Journal of Photochemistry and Photobiology B: Biology

Volumn 126, Issue , 2013, Pages 26-32

  Middelburg, T A ^a   De Bruijn, H S ^a   Tettero, L ^a   Van Der Ploeg Van Den Heuvel, A ^a   Neumann, H A M ^a   De Haas, E R M ^a   Robinson, D J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ALA; HAL; PDT; PpIX distribution; Vascular effect; Vasoconstriction

Indexed keywords

AMINOLEVULINIC ACID; HEXYLAMINOLEVULINATE; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL WALL; CONFOCAL LASER MICROSCOPY; CONFOCAL MICROSCOPE; FEMALE; FLUORESCENCE; LASER; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKINFOLD; VASOCONSTRICTION; VENULE;

ALA; HAL; PDT; PPIX DISTRIBUTION; VASCULAR EFFECT; VASOCONSTRICTION;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMALS; ARTERIOLES; MICE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; VASOCONSTRICTION;

EID: 84885117937     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/jjphotobiol.2013.06.014     Document Type: Article

References (51)

1. B.W. Henderson, T.J. Dougherty, How does photodynamic therapy work?, Photochem Photobiol. 55 (1) (1992) 145-157.
2. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, et al., Photodynamic therapy, J. Natl. Cancer Inst. 90 (12) (1998) 889-905. (Pubitemid 28304157)
3. K.R. Weishaupt, C.J. Gomer, T.J. Dougherty, Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor, Cancer Res. 36 (7 PT 1) (1976) 2326-2329.
4. F.H. van Duijnhoven, R.I. Aalbers, J.P. Rovers, O.T. Terpstra, P.J. Kuppen, The immunological consequences of photodynamic treatment of cancer, a literature review, Immunobiology 207 (2) (2003) 105-113. (Pubitemid 36367383)
5. A. Juarranz, P. Jaen, F. Sanz-Rodriguez, J. Cuevas, S. Gonzalez, Photodynamic therapy of cancer. Basic principles and applications, Clin. Transl. Oncol. 10 (3) (2008) 148-154.
6. B. Krammer, Vascular effects of photodynamic therapy, Anticancer Res. 21 (6B) (2001) 4271-4277. (Pubitemid 34245368)
7. D.J. Robinson, H.S. de Bruijn, N. van der Veen, M.R. Stringer, S.B. Brown, W.M. Star, Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect, Photochem. Photobiol. 67 (1) (1998) 140-149. (Pubitemid 128471972)
8. T.A. Middelburg, F. Van Zaane, H.S. De Bruijn, A. Van Der Ploeg-van den Heuvel, H.J. Sterenborg, H.A. Neumann, et al., Fractionated illumination at low fluence rate photodynamic therapy in mice, Photochem. Photobiol. 86 (5) (2010) 1140-1146. doi:10.11/j.751-097.2010.00760.x.
9. M. Ascencio, P. Collinet, M.O. Farine, S. Mordon, Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy, Lasers Surg. Med. 40 (5) (2008) 332-341. (Pubitemid 351920383)
10. J.S. Tyrrell, S.M. Campbell, A. Curnow, The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome, Lasers Surg. Med. 42 (7) (2010) 613-619.
11. K. Chaudhuri, R.W. Keck, S.H. Selman, Morphological changes of tumor microvasculature following hematoporphyrin derivative sensitized photodynamic therapy, Photochem. Photobiol. 46 (5) (1987) 823-827.
12. T.J. Wieman, T.S. Mang, V.H. Fingar, T.G. Hill, M.W. Reed, T.S. Corey, et al., Effect of photodynamic therapy on blood flow in normal and tumor vessels, Surgery 104 (3) (1988) 512-517.
13. M.W. Reed, T.J. Wieman, D.A. Schuschke, M.T. Tseng, F.N. Miller, A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation, Radiat. Res. 119 (3) (1989) 542-552. (Pubitemid 19234980)
14. J. Feyh, A. Goetz, A. Heimann, R. Konigsberger, E. Kastenbauer, Microcirculatory effects of photodynamic therapy with hematoporphyrin derivative, Laryngorhinootologie 70 (2) (1991) 99-101.
15. V.H. Fingar, T.J. Wieman, S.A. Wiehle, P.B. Cerrito, The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion, Cancer Res. 52 (18) (1992) 4914-4921.
16. M.A. Herman, D. Fromm, D. Kessel, Tumor blood-flow changes following protoporphyrin IX-based photodynamic therapy in mice and humans, J. Photochem. Photobiol. B 52 (1-3) (1999) 99-104. (Pubitemid 30011501)
17. J. Leveckis, N.J. Brown, M.W. Reed, The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo, Br. J. Cancer 72 (5) (1995) 1113-1119.
18. B.W. Henderson, L. Vaughan, D.A. Bellnier, H. van Leengoed, P.G. Johnson, A.R. Oseroff, Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin, Photochem. Photobiol. 62 (4) (1995) 780-789.
19. T.L. Becker, A.D. Paquette, K.R. Keymel, B.W. Henderson, U. Sunar, Monitoring blood flow responses during topical ALA-PDT, Biomed. Opt. Express 2 (1) (2010) 123-130.
20. I. Wang, S. Andersson-Engels, G.E. Nilsson, K. Wardell, K. Svanberg, Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser Doppler perfusion imaging, Br. J. Dermatol. 136 (2) (1997) 184-189. (Pubitemid 27062717)
21. N. van der Veen, K.M. Hebeda, H.S. de Bruijn, W.M. Star, Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single-or two-fold illumination, Photochem. Photobiol. 70 (6) (1999) 921-929. (Pubitemid 129548338)
22. H. de Vijlder, H. de Bruijn, A. van der Ploeg-van den Heuvel, F. van Zaane, D. Schipper, T. ten Hagen, et al., Photodynamic therapy using topically applied porphyrin precursors induces vascular effects, J. Photodiagnosis Photodyn. Ther. (2013) (in press).
23. V. Schacht, R.M. Szeimies, C. Abels, Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application, Photochem. Photobiol. Sci. 5 (5) (2006) 452-458 (Epub 2006 Mar 30). (Pubitemid 43725965)
24. A. Juzeniene, P. Juzenas, V. Iani, J. Moan, Reflectance spectroscopy and fluorescein angiography applied to assess photodynamic response in healthy mouse skin treated with topical hexylaminolevulinate, J. Photodiagnosis Photodyn. Ther. 7 (4) (2010) 239-245 (Epub 2010 Jul 31).
25. A. Juzeniene, K.P. Nielsen, L. Zhao, G.A. Ryzhikov, M.S. Biryulina, J.J. Stamnes, et al., Changes in human skin after topical PDT with hexyl aminolevulinate, J. Photodiagnosis Photodyn. Ther. 5 (3) (2008) 176-181 (Epub 2008 Aug 28).
26. T. Smits, M.M. Kleinpenning, W.A. Blokx, P.C. van de Kerkhof, P.E. van Erp, M.J. Gerritsen, Fluorescence diagnosis in keratinocytic intraepidermal neoplasias, J. Am. Acad. Dermatol. 57 (5) (2007) 824-831 (Epub 2007 Jul 31). (Pubitemid 47553081)
27. E. Rud, O. Gederaas, A. Hogset, K. Berg, 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters, Photochem. Photobiol. 71 (5) (2000) 640-647.
28. L. Rodriguez, A. Batlle, G. Di Venosa, S. Battah, P. Dobbin, A.J. Macrobert, et al., Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells, Br. J. Pharmacol. 147 (7) (2006) 825-833.
29. L. Rodriguez, A. Batlle, G. Di Venosa, A.J. MacRobert, S. Battah, H. Daniel, et al., Study of the mechanisms of uptake of 5-aminolevulinic acid derivatives by PEPT1 and PEPT2 transporters as a tool to improve photodynamic therapy of tumours, Int. J. Biochem. Cell Biol. 38 (9) (2006) 1530-1539 (Epub 2006 Mar 18). (Pubitemid 44250952)
30. R. Schulten, B. Novak, B. Schmitz, H. Lubbert, Comparison of the uptake of 5-aminolevulinic acid and its methyl ester in keratinocytes and skin, Naunyn Schmiedebergs Arch. Pharmacol. 385 (10) (2012) 969-979, http://dx.doi.org/10. 1007/s00210-012-0777-4 (Epub 2012 Jul 17).
31. P. Uehlinger, M. Zellweger, G. Wagnieres, L. Juillerat-Jeanneret, H. van den Bergh, N. Lange, 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells, J. Photochem. Photobiol. B 54 (1) (2000) 72-80. (Pubitemid 30124231)
32. L. Rodriguez, H.S. de Bruijn, G. Di Venosa, L. Mamone, D.J. Robinson, A. Juarranz, et al., Porphyrin synthesis from aminolevulinic acid esters in endothelial cells and its role in photodynamic therapy, J. Photochem. Photobiol. B 96 (3) (2009) 249-254 (Epub 2009 Jul 5).
33. H. de Vijlder, H. de Bruijn, A. van der Ploeg-van den Heuvel, H. Sterenborg, H. Neumann, E. de Haas, et al., Differences in protoporphyrin IX localisation in dermal vasculature after topical application of 5-aminolevulinic acid and methyl-5 aminolevulinate, J. Photochem. Photobiol. (2013) (in press).
34. S. Kascakova, S. de Visscher, B. Kruijt, H.S. de Bruijn, A. van der Ploeg-van den Heuvel, H.J. Sterenborg, et al., In vivo quantification of photosensitizer fluorescence in the skin-fold observation chamber using dual-wavelength excitation and NIR imaging, Lasers Med. Sci. 26 (6) (2011) 789-801, http://dx.doi.org/10.1007/s10103-011-0888-(Epub 2011 Jan 29).
35. G. Di Venosa, A. Batlle, H. Fukuda, A. Macrobert, A. Casas, Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues, Cancer Chemother. Pharmacol. 58 (4) (2006) 478-486 (Epub 2006 Feb 17). (Pubitemid 43999796)
36. L. Zhao, K.P. Nielsen, A. Juzeniene, P. Juzenas, V. Lani, L.W. Ma, et al., Spectroscopic measurements of photoinduced processes in human skin after topical application of the hexyl ester of 5-aminolevulinic acid, J. Environ. Pathol. Toxicol. Oncol. 25 (1-2) (2006) 307-320. (Pubitemid 43341249)
37. S. Palsson, L. Gustafsson, N. Bendsoe, M. Soto Thompson, S. Andersson-Engels, K. Svanberg, Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolaevulinic acid, Br. J. Dermatol. 148 (6) (2003) 1179-1188. (Pubitemid 36819218)
38. A. Casas, C. Perotti, H. Fukuda, L. Rogers, A.R. Butler, A. Batlle, ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization, Br. J. Cancer 85 (11) (2001) 1794-1800. (Pubitemid 34081529)
39. N. Dognitz, D. Salomon, M. Zellweger, J.P. Ballini, T. Gabrecht, N. Lange, et al., Comparison of ALA-and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma, J. Photochem. Photobiol. B 93 (3) (2008) 140-148 (Epub 2008 Aug 17).
40. E. Endlicher, P. Rummele, F. Hausmann, R. Krieg, R. Knuchel, H.C. Rath, et al., Protoporphyrin IX distribution following local application of 5-aminolevulinic acid and its esterified derivatives in the tissue layers of the normal rat colon, Br. J. Cancer 85 (10) (2001) 1572-1576. (Pubitemid 34001592)
41. A. Juzeniene, P. Juzenas, L.W. Ma, V. Iani, J. Moan, Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin, Br. J. Dermatol. 155 (4) (2006) 791-799. (Pubitemid 44352561)
42. A. Marti, P. Jichlinski, N. Lange, J.P. Ballini, L. Guillou, H.J. Leisinger, et al., Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer, J. Urol. 170 (2 Pt 1) (2003) 428-432. (Pubitemid 36870217)
43. J.T. van den Akker, J.A. Holroyd, D.I. Vernon, H.J. Sterenborg, S.B. Brown, Comparative in vitro percutaneous penetration of 5-aminolevulinic acid and two of its esters through excised hairless mouse skin, Lasers Surg. Med. 33 (3) (2003) 173-181. (Pubitemid 37237398)
44. J. Moan, L.W. Ma, A. Juzeniene, V. Iani, P. Juzenas, F. Apricena, et al., Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters, Int. J. Cancer 103 (1) (2003) 132-135. (Pubitemid 35424217)
45. C. Perotti, A. Casas, H. Fukuda, P. Sacca, A. Batlle, Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution, Br. J. Cancer 88 (3) (2003) 432-437. (Pubitemid 36308156)
46. E.R. de Haas, B. Kruijt, H.J. Sterenborg, H.A. Martino Neumann, D.J. Robinson, Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy, J. Invest. Dermatol. 126 (12) (2006) 2679-2686 (Epub 006 Jul 13). (Pubitemid 44764052)
47. H.S. de Bruijn, E.R. de Haas, K.M. Hebeda, A. van der Ploeg-van den Heuvel, H.J. Sterenborg, H.A. Neumann, et al., Light fractionation does not enhance the efficacy of methyl 5-aminolevulinate mediated photodynamic therapy in normal mouse skin, Photochem. Photobiol. Sci. 6 (12) (2007) 1325-1331 (Epub 2007 Aug 28). (Pubitemid 350191107)
48. M. Ascencio, J.P. Estevez, M. Delemer, M.O. Farine, P. Collinet, S. Mordon, Comparison of continuous and fractionated illumination during hexaminolaevulinate-photodynamic therapy, J. Photodiagnosis Photodyn. Ther. 5 (3) (2008) 210-216 (Epub 2008 Oct 19).
49. A.J. Bedlow, A.W. Stanton, S. Cliff, P.S. Mortimer, Basal cell carcinoma-an in-vivo model of human tumour microcirculation?, Exp Dermatol. 8 (3) (1999) 222-226. (Pubitemid 29256307)
50. T.W. Grunt, A. Lametschwandtner, O. Staindl, The vascular pattern of basal cell tumors: light microscopy and scanning electron microscopic study on vascular corrosion casts, Microvasc. Res. 29 (3) (1985) 371-386. (Pubitemid 16158231)
51. T.A. Middelburg, S.C. Kanick, E.R. de Haas, H.J. Sterenborg, A. Amelink, M.H. Neumann, et al., Monitoring blood volume and saturation using superficial fibre optic reflectance spectroscopy during PDT of actinic keratosis, J. Biophotonics 4 (10) (2011) 721-730, http://dx.doi.org/10.1002/jbio.201100053 (Epub 2011 Aug 15).